First PRIZM Participant Enrolled in Tisento`s MELAS Study
20 Aug 2025 //
GLOBENEWSWIRE
Tisento Doses First Patient In Zagociguat Phase 2b PRIZM Study
27 Jan 2025 //
GLOBENEWSWIRE
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
11 May 2023 //
GLOBENEWSWIRE